| Literature DB >> 17051621 |
Daniel Sommermeyer1, Julia Neudorfer, Monika Weinhold, Matthias Leisegang, Boris Engels, Elfriede Noessner, Mirjam H M Heemskerk, Jehad Charo, Dolores J Schendel, Thomas Blankenstein, Helga Bernhard, Wolfgang Uckert.
Abstract
T cell receptor (TCR) gene transfer is a convenient method to produce antigen-specific T cells for adoptive therapy. However, the expression of two TCR in T cells could impair their function or cause unwanted effects by mixed TCR heterodimers. With five different TCR and four different T cells, either mouse or human, we show that some TCR are strong--in terms of cell surface expression--and replace weak TCR on the cell surface, resulting in exchange of antigen specificity. Two strong TCR are co-expressed. A mouse TCR replaces human TCR on human T cells. Even though it is still poorly understood why some TCRalpha/beta combinations are preferentially expressed on T cells, our data suggest that, in the future, designer T cells with exclusive tumor reactivity can be generated by T cell engineering.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17051621 DOI: 10.1002/eji.200636539
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532